Oorsprong van het eerstegraads netwerk van John Patrick Kearney
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Amgen Ltd.
 Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John Patrick Kearney via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| McGill University | College/University | Doctorate Degree | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Amgen Research (Munich) GmbH
 Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Part of Amgen, Inc., Amgen Research (Munich) GmbH is a biotechnology company based in Munich, Germany. The company has over 850 employees working at two locations in Germany. Amgen Scholars Europe Programs offer practical research experience to 100 students from all over Europe every summer. The company utilizes biotechnological possibilities to develop innovative treatments for diseases. The company continuously develops new substances to provide biopharmaceuticals to patients worldwide with serious illnesses. The CEOs of the company are Peter Kufer and Robert Saller. Amgen Research (Munich was acquired by ECKA Granulate GmbH & Co. KG from Aurubis AG on June 13, 2002. | Metal Fabrication | Chief Executive Officer | |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| ZAI LAB LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Seville | College/University | Doctorate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Asterion Ltd.
 Asterion Ltd. BiotechnologyHealth Technology Asterion Ltd. develops novel therapeutic products. It offers drugs for patients with chronic, debilitating diseases. The company was founded by Richard John Martin Ross, Peter Artymiuk and Jon R. Sayers in 2001 and is headquartered in Sheffield, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Synox Therapeutics Ltd.
 Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
| Manchester Business School | College/University | Masters Business Admin | |
My Goodness Ltd.
 My Goodness Ltd. Beverages: Non-AlcoholicConsumer Non-Durables My Goodness Ltd. produces sports drinks. It contains electrolytes, carbohydrates and other nutrients which are essential for athletes before, after and during exercise. The company was founded by Stuart Jeffreys and Jeremy Martin in 2003 and is headquartered in London, the United Kingdom. | Beverages: Non-Alcoholic | Director/Board Member | |
| University of Leeds | College/University | Undergraduate Degree | |
| E-THERAPEUTICS PLC | Biotechnology | Chief Executive Officer | |
BD Solutions Ltd.
 BD Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services BD Solutions Ltd. Provides computer support and services. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Founder | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Emergent Product Development UK Ltd.
 Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Emergent Product Development (UK) Ltd. develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax. It also develops vaccines for meningitis and another for streptococcal infections for infants. The company is a biotechnology company focused on harnessing the immune system to treat and prevent disease in areas of significant unmet clinical needs. It was founded in 1996 and is located in Wokingham, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigd Koninkrijk | 12 |
| Verenigde Staten | 5 |
| Israël | 3 |
| Duitsland | 3 |
| Canada | 2 |
Sectoraal
| Health Technology | 15 |
| Consumer Services | 7 |
| Commercial Services | 3 |
| Producer Manufacturing | 2 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 10 |
| Corporate Officer/Principal | 9 |
| Chief Executive Officer | 6 |
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 3 |
Sterkste connecties
- Beurs
- Insiders
- John Patrick Kearney
- Bedrijfsconnecties
